Hemostemix Inc.
HMTXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14,329 | $18,149 | $7,385 | $9,229 |
| - Cash | $831 | $679 | $965 | $706 |
| + Debt | $2,473 | $4,866 | $4,693 | $4,937 |
| Enterprise Value | $15,971 | $22,336 | $11,113 | $13,460 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$305 | -$135 | -$1,118 | -$1,844 |
| % Margin | – | – | – | – |
| Net Income | -$357 | -$308 | -$1,285 | -$2,302 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.002 | -0.014 | -0.024 |
| % Growth | -14.3% | 84.4% | 44.2% | – |
| Operating Cash Flow | -$2,086 | -$801 | $337 | -$1,810 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,086 | -$801 | $337 | -$1,810 |